Fountainhead AM LLC Cuts Stake in Procter & Gamble Company (The) $PG

Fountainhead AM LLC lessened its stake in Procter & Gamble Company (The) (NYSE:PG) by 47.2% during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 5,447 shares of the company’s stock after selling 4,875 shares during the quarter. Fountainhead AM LLC’s holdings in Procter & Gamble were worth $868,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Kingstone Capital Partners Texas LLC grew its position in shares of Procter & Gamble by 655,209.0% during the second quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company’s stock valued at $11,832,680,000 after purchasing an additional 76,017,350 shares in the last quarter. Northern Trust Corp boosted its stake in Procter & Gamble by 0.8% during the first quarter. Northern Trust Corp now owns 29,644,000 shares of the company’s stock valued at $5,051,930,000 after buying an additional 248,792 shares during the last quarter. Price T Rowe Associates Inc. MD grew its holdings in Procter & Gamble by 13.0% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company’s stock valued at $3,660,737,000 after buying an additional 2,466,308 shares in the last quarter. Goldman Sachs Group Inc. increased its stake in Procter & Gamble by 3.5% in the 1st quarter. Goldman Sachs Group Inc. now owns 17,405,539 shares of the company’s stock worth $2,966,252,000 after acquiring an additional 583,629 shares during the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in shares of Procter & Gamble by 6.3% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 17,293,428 shares of the company’s stock worth $2,947,146,000 after acquiring an additional 1,018,865 shares in the last quarter. Institutional investors own 65.77% of the company’s stock.

Insiders Place Their Bets

In related news, CFO Andre Schulten sold 4,252 shares of Procter & Gamble stock in a transaction dated Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total transaction of $647,281.96. Following the completion of the sale, the chief financial officer owned 53,992 shares in the company, valued at $8,219,202.16. This trade represents a 7.30% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, COO Shailesh Jejurikar sold 3,986 shares of the business’s stock in a transaction dated Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total transaction of $606,788.78. Following the completion of the sale, the chief operating officer directly owned 46,899 shares of the company’s stock, valued at approximately $7,139,434.77. This trade represents a 7.83% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders have sold 150,488 shares of company stock valued at $23,529,718. Insiders own 0.20% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages recently weighed in on PG. Evercore ISI restated an “in-line” rating and issued a $170.00 price target (down previously from $190.00) on shares of Procter & Gamble in a research report on Monday, July 14th. Morgan Stanley set a $175.00 price objective on shares of Procter & Gamble in a research note on Monday, October 27th. JPMorgan Chase & Co. upped their target price on shares of Procter & Gamble from $163.00 to $165.00 and gave the company a “neutral” rating in a research report on Monday, October 27th. BNP Paribas reiterated an “outperform” rating and issued a $177.00 price target on shares of Procter & Gamble in a research report on Friday, August 15th. Finally, BNP Paribas Exane reduced their price objective on Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating on the stock in a research note on Tuesday, September 23rd. Twelve research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Procter & Gamble has an average rating of “Moderate Buy” and a consensus target price of $171.53.

Procter & Gamble Price Performance

PG stock opened at $146.90 on Monday. The stock has a market cap of $343.28 billion, a PE ratio of 21.45, a P/E/G ratio of 3.87 and a beta of 0.36. Procter & Gamble Company has a 12 month low of $144.46 and a 12 month high of $180.43. The company has a 50-day moving average price of $152.93 and a 200 day moving average price of $157.02. The company has a current ratio of 0.71, a quick ratio of 0.51 and a debt-to-equity ratio of 0.46.

Procter & Gamble (NYSE:PG) last announced its quarterly earnings data on Friday, October 24th. The company reported $1.99 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.90 by $0.09. The business had revenue of $22.39 billion during the quarter, compared to the consensus estimate of $22.23 billion. Procter & Gamble had a net margin of 19.74% and a return on equity of 32.63%. The firm’s quarterly revenue was up 3.0% compared to the same quarter last year. During the same quarter last year, the firm earned $1.93 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.100 EPS. Equities research analysts anticipate that Procter & Gamble Company will post 6.91 earnings per share for the current year.

Procter & Gamble Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, November 17th. Shareholders of record on Friday, October 24th will be given a $1.0568 dividend. This represents a $4.23 annualized dividend and a yield of 2.9%. The ex-dividend date of this dividend is Friday, October 24th. Procter & Gamble’s dividend payout ratio is 61.61%.

Procter & Gamble Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.